CTOs on the Move


 
Create the most delightful experiences for our guests. We believe we can positively change the way people think about alternative lodging. The process begins by seeking out high-quality homes with modern spaces and prime locations, to ensure our designers can bring out the natural beauty of each property and to give you an authentic travel experience. We deck out each Domio with curated furniture, accessories and artwork to create a distinguished level of style and comfort, and provide round-the-clock concierge services for your convenience. With Domio, feel at home anywhere in the world.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Domio raised $50M on 09/24/2018
Domio raised $12M on 10/19/2018
Domio raised $50M on 12/18/2019

Similar Companies

Government Scientific Source, Inc.

Government Scientific Source, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Reston, VA. To find more information about Government Scientific Source, Inc., please visit www.govsci.com

Impact Cryotherapy

Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company`s state-of-the-art cryosaunas are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.

Jeffrey J Eckardt

Jeffrey J Eckardt is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeurogesX, Inc.

NeurogesX, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Foster City, CA. To find more information about NeurogesX, Inc., please visit www.neurogesx.com

Cynvenio Biosystems Inc

Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.